Objective:
To promote YUVEZZI, a prescription eye drop for treating presbyopia, through a national direct-to-consumer campaign, as reported by Business Wire.
Approach:
- Campaign Theme: The campaign, titled Friends of the Presbyopians, uses hand-crafted puppets to illustrate frustrations related to blurry close-up vision.
- Media Channels: The campaign is launching nationwide across digital and social channels.
Key Findings:
- YUVEZZI is a dual-agent ophthalmic solution containing carbachol and brimonidine tartrate.
- It is approved for adults with age-related blurry near vision.
- Presbyopia affects about 128 million adults in the US and approximately 2 billion people globally.
- YUVEZZI provided up to eight continuous hours of improved close-up vision in medical studies.
- Common side effects include headache, impaired vision, and temporary eye pain or irritation.
Interpretation:
The campaign aims to raise awareness about presbyopia and encourage discussions with eye care professionals.
Conclusion:
The campaign represents a strategic effort by Tenpoint Therapeutics to build market momentum for YUVEZZI, according to Henric Bjarke, CEO of Tenpoint Therapeutics.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
